Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.

TitleIncreased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.
Publication TypeJournal Article
Year of Publication2023
AuthorsMohan, M, Janz, S, Brazauskas, R, Dwinell, MB, Teng, BQing, Yun, G, Dong, J, Pasquini, MC, Giralt, S, Landau, H, Stadtmauer, E, Krishnan, A, D'Souza, A
JournalBone Marrow Transplant
Date Published2023 May 06
ISSN1476-5365
DOI10.1038/s41409-023-02004-5
Alternate JournalBone Marrow Transplant
PubMed ID37149674
PubMed Central ID3609759
Grant ListR01 CA151354 / CA / NCI NIH HHS / United States
K23 HL141445 / HL / NHLBI NIH HHS / United States
R01 CA226279 / CA / NCI NIH HHS / United States